Navigation Links
Boehringer Ingelheim's Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
Date:11/1/2010

formulary coverage and anticipate PRADAXA will be reimbursed at a co-pay level similar to other preferred branded products.  Programs that offer financial assistance to those who may otherwise be unable to afford medication also are available through the BI CARES Foundation. 

"Treatment with PRADAXA does not require routine blood monitoring or related dose adjustments.  In addition, there are no recommended dietary restrictions," said Christopher Corsico, M.D., MPH, medical director, Boehringer Ingelheim Pharmaceuticals, Inc.  "PRADAXA has the potential to significantly impact the treatment paradigm for patients with non-valvular atrial fibrillation.  We are working with insurers to make PRADAXA as affordable and accessible as possible."

PRADAXA 150mg taken twice daily has been shown to significantly reduce stroke and systemic embolism by 35 percent beyond the reduction achieved with warfarin,(1) the current standard of care for patients with non-valvular atrial fibrillation.  PRADAXA 150mg taken twice daily has been shown to significantly reduce both ischemic strokes (caused by blood clots) and hemorrhagic strokes (caused by bleeding) compared to warfarin. (1)  A 75mg twice daily dose of PRADAXA also is approved for the small subset of patients who have severe renal impairment. (1)  

About Atrial Fibrillation and Stroke

Atrial fibrillation (AFib), characterized by an irregular heartbeat,(2) can cause blood clots to form in the heart that can travel to the brain and cause a stroke.(2) An estimated 2.3 million Americans are living with AFib, (3) and the prevalence is expected to increase to 5.6 million by 2050.(3) A large managed care database study showed that non-valvular atrial fibrillation represents approximately 95 percent of all atrial fibrillation cases in the U.S. (3)  Atrial fibrillation increases the risk of stroke nearly five times (4)and is associat
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März ... Gates Stiftung und das deutsche biopharmazeutische Unternehmen ... 46 Millionen Euro (52 Millionen US-Dollar) in ... Bereich der medizinisch angewandten Messenger-RNA (mRNA). Auf ... Ansätze zur Behandlung von Krankheiten und zum ...
(Date:3/5/2015)... 2015  As the pharmaceutical industry works to ... Compliance professionals are placing a significant emphasis on ... today by LRN, the leader in Ethics & ... of respondents expressed that clarity on company values ... E&C training programs (57%), trumping understanding of the ...
(Date:3/5/2015)... WHIPPANY, N.J. , March 5, 2015 ... million dollars to the Conquer Cancer Foundation of the ... a cutting edge health information technology platform designed to ... people living with cancer.  "Bayer is ... in their efforts to leverage Big Data to help ...
Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3
... Misonix, Inc. (Nasdaq: MSON ), a developer ... which worldwide is used for acute health conditions, today ... 2010 financial results on Monday, November 15, 2010.  Michael ... Zaremba, Senior VP and Chief Financial Officer, will host ...
... 2010 NexBio, Inc. announced the presentation of ... of Allergy, Asthma, and Immunology in Phoenix, Arizona. ... Decreases Airway Resistance by Modulating Muscarinic Receptor Signaling." ... investigational broad spectrum host-targeting antiviral drug candidate undergoing ...
Cached Medicine Technology:Misonix Schedules First Quarter 2011 Financial Results Conference Call; November 15, 2010 at 4:30 P.M. Eastern 2NexBio Presents Data at ACAAI 2010 Demonstrating Mechanism of Action for Improvement in Airway Function by DAS181 (Fludase®*) 2NexBio Presents Data at ACAAI 2010 Demonstrating Mechanism of Action for Improvement in Airway Function by DAS181 (Fludase®*) 3
(Date:3/5/2015)... 2015 Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) ... attacks, strokes and other serious cardiovascular events due to ... move forward in the federal multidistrict litigation now underway ... to a Case Management Order issued on March 3rd, ... of master pleadings in the proceeding. Among other things, ...
(Date:3/5/2015)... The Maricopa Community Colleges ... the Arizona economy each year, according to a research ... Value of Maricopa County Community College District, summarizes economic ... in fiscal year 2013-2014. , The analysis was ... an organization that specializes in providing economic impact studies ...
(Date:3/5/2015)... March 05, 2015 TCS Healthcare Technologies ... for the population health management arena, is pleased to ... management software, ACUITY Advanced Care™ (ACUITY) version 7.20. The ... performance and the advantages of automation. , The webinar, ... will be led by Jeff Frater, RN, BSN, Director ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Califia ... leader in the natural products coffee drinks category[1], today ... Products Expo West in Anaheim, Calif. Concentrated Cold ... concept, Califia Café, which democratizes the next wave of ... ingredients they need to become their own baristas. ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 For PASCHA ... and most essential ingredients, the robust flavor of the ... reactions. PASCHA Chocolate is free from peanuts, nuts, ... Experience PASCHA's offering March 6th- 8th at Expo West., ... PASCHA Chocolate has broken new ground with their ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2
... 8, 2011 Children who suffer from persistent or recurring ... are at risk of developing internalizing symptoms such as anxiety, ... review of chronic pain in children and adolescents in 20 ... are suffering from chronic pain and that girls suffer more ...
... , THURSDAY, Dec. 8 (HealthDay News) -- Breast cancer ... have a 10 percent greater risk for developing cancer in ... woman receives her first diagnosis before age 40, new research ... [with this mutation] who have already had cancers are also ...
... Los Angeles, CA (DECEMBER 8, 2011) Young football players may ... study released in Journal of Child Neurology (JCN), ... and Dr. Meredith R. Golomb looked at various case studies ... and found some potential causes for strokes in young football ...
... THURSDAY, Dec. 8 (HealthDay News) -- Rats may have ... scroungers, a new study found that the rodents showed ... companions, even when they,re given the opportunity to eat ... in rodents suggests that this type of pro-social helping ...
... that combines an adjusted blood test with other factors including ... family history, can help up to one-quarter of men avoid ... Deaconess Medical Center-led research team says. Writing in a ... team led by Martin G. Sanda, MD, Director of the ...
... Lunenfeld Research Institute,s Drs. Frank Sicheri, Tony Pawson and ... the Ontario Cancer Institute, have uncovered the detailed architecture ... to the bone development disorder cherubism and involved in ... first structural insight into precisely how the enzyme correctly ...
Cached Medicine News:Health News:Chronic pain in children and adolescents becoming more common 2Health News:Breast Cancer Gene Puts Survivors at Higher Odds for Recurrence 2Health News:Rats Can Lend a Helping Paw to Others, Study Finds 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 3Health News:Toronto researchers obtain detailed molecular 'signature' for Tankyrase 2Health News:Toronto researchers obtain detailed molecular 'signature' for Tankyrase 3
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Maumenee vitreous aspirating cannula, 18 gauge....
Reusable blunt cannula with luer hub. Cannula length is 32 mm....
Medicine Products: